We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRNA
2926
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$29K ﹤0.01%
68,253
+782
+1% +$600
LNAI
2927
Lunai Bioworks
LNAI
$10.9M
$28K ﹤0.01%
381
+15
+4% +$1.32K
ATIP
2928
DELISTED
ATI Physical Therapy, Inc.
ATIP
$28K ﹤0.01%
2,188
+9
+0.4% +$164
JOAN
2929
DELISTED
JOANN, Inc. Common Stock
JOAN
$27K ﹤0.01%
17,009
+68
+0.4% +$219
STLN
2930
Starling Oncology, Inc. Common Stock
STLN
$641M
$26K ﹤0.01%
38,600
+1,818
+5% +$2.32K
LIDR icon
2931
AEye
LIDR
$61.1M
$24K ﹤0.01%
2,579
+46
+2% +$793
AUD
2932
DELISTED
Audacy, Inc.
AUD
$23K ﹤0.01%
173,034
+744
+0.4% +$171
KLR
2933
DELISTED
Kaleyra, Inc.
KLR
$21K ﹤0.01%
12,722
+256
+2% +$812
CISO
2934
CISO Global
CISO
$12.1M
$20K ﹤0.01%
3,959
+249
+7% +$4.06K
CPTN
2935
DELISTED
Cepton, Inc. Common Stock
CPTN
$20K ﹤0.01%
4,365
+62
+1% +$612
WEJO
2936
DELISTED
Wejo Group Limited Common Shares
WEJO
$20K ﹤0.01%
40,988
+8,020
+24% +$5.02K
HLGN
2937
DELISTED
Heliogen, Inc.
HLGN
$19K ﹤0.01%
2,205
+16
+0.7% +$243
ISPO
2938
DELISTED
Inspirato
ISPO
$18K ﹤0.01%
951
+6
+0.6% +$139
PEAR
2939
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$17K ﹤0.01%
65,539
+548
+0.8% +$495
OWLT icon
2940
Owlet
OWLT
$160M
$15K ﹤0.01%
3,369
+2,140
+174% +$12.7K
CYXT
2941
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$15K ﹤0.01%
50,115
+321
+0.6% +$679
ZOM
2942
DELISTED
Zomedica Corp.
ZOM
$15K ﹤0.01%
69,911
ZEV
2943
DELISTED
Lightning eMotors, Inc.
ZEV
$13K ﹤0.01%
2,328
+12
+0.5% +$140
SUNL
2944
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$13K ﹤0.01%
2,130
+72
+3% +$1.59K
FATH
2945
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$12K ﹤0.01%
1,115
+391
+54% +$9.12K
BOXD
2946
DELISTED
Boxed, Inc.
BOXD
$11K ﹤0.01%
57,694
+7,362
+15% +$3.31K
LFLY
2947
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$9K ﹤0.01%
1,116
+180
+19% +$2.01K
TALK icon
2948
Talkspace
TALK
$874M
$8K ﹤0.01%
11,602
VIP
2949
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$37.2M
$7K ﹤0.01%
1,473
+9
+0.6% +$54
AKA icon
2950
a.k.a. Brands
AKA
$119M
$6K ﹤0.01%
936
-39
-4% -$591

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.